In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 13327-27-0, name is 6-Methylpyridazin-3(2H)-one, introducing its new discovery. Recommanded Product: 6-Methylpyridazin-3(2H)-one
The present invention provides an integrase inhibitor. The inventors have have found the following compound of formula (I) possessing an integrase inhibitory activity. (wherein, R C and R D taken together with the neighboring carbon atoms form a ring which may be a condensed ring, Y is hydroxy, mercapto or amino; Z is O, S or NH ; R A is a group shown by (wherein, C ring is N-containing aromatic heterocycle) or the like)
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 13327-27-0, and how the biochemistry of the body works.Recommanded Product: 6-Methylpyridazin-3(2H)-one
Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N285 – PubChem